These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16395992)

  • 1. Therapeutic equivalence--clinical issues and statistical methodology in noninferiority trials.
    Munk A; Trampisch HJ
    Biom J; 2005 Feb; 47(1):7-9; discussion 99-107. PubMed ID: 16395992
    [No Abstract]   [Full Text] [Related]  

  • 2. Superior safety in noninferiority trials.
    Bristol DR
    Biom J; 2005 Feb; 47(1):75-81; discussion 99-107. PubMed ID: 16395998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Testing superiority and non-inferiority hypotheses in active controlled clinical trials".
    Röhmel J; Hauschke D
    Biom J; 2006 Feb; 48(1):174-5; author reply 176. PubMed ID: 16544822
    [No Abstract]   [Full Text] [Related]  

  • 4. Methods for assessing noninferiority with censored data.
    Freitag G
    Biom J; 2005 Feb; 47(1):88-98; discussion 99-107. PubMed ID: 16396000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trials.
    Hung HM; Wang SJ; O'Neill R
    Biom J; 2005 Feb; 47(1):28-36; discussion 99-107. PubMed ID: 16395994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of delta: requirements and reality--results of a systematic review.
    Lange S; Freitag G
    Biom J; 2005 Feb; 47(1):12-27; discussion 99-107. PubMed ID: 16395993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems with existing procedures to calculate exact unconditional P-values for non-inferiority/superiority and confidence intervals for two binomials and how to resolve them.
    Röhmel J
    Biom J; 2005 Feb; 47(1):37-47; discussion 99-107. PubMed ID: 16395995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical methods for the analysis of two-arm non-inferiority trials with binary outcomes.
    Wellek S
    Biom J; 2005 Feb; 47(1):48-61; discussion 99-107. PubMed ID: 16395996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing superiority and non-inferiority hypotheses in active controlled clinical trials.
    Tsong Y; Zhang JJ
    Biom J; 2005 Feb; 47(1):62-74; discussion 99-107. PubMed ID: 16395997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues of simultaneous tests for noninferiority and superiority.
    Ng TH
    J Biopharm Stat; 2003 Nov; 13(4):629-39; discussion 641-62. PubMed ID: 14584713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biostatistical assessment of mutagenicity studies by including the positive control.
    Hauschke D; Slacik-Erben R; Hensen S; Kaufmann R
    Biom J; 2005 Feb; 47(1):82-7; discussion 99-107. PubMed ID: 16395999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality.
    Gomberg-Maitland M; Frison L; Halperin JL
    Am Heart J; 2003 Sep; 146(3):398-403. PubMed ID: 12947355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical issues in equivalence trials.
    Ebbutt AF; Frith L
    Stat Med; 1998 Aug 15-30; 17(15-16):1691-701. PubMed ID: 9749440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic equivalence investigations: statistical considerations.
    Röhmel J
    Stat Med; 1998 Aug 15-30; 17(15-16):1703-14. PubMed ID: 9749441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninferiority drug trials fail to report adequate methodological detail: an assessment of noninferiority trials from 2010 to 2015.
    Hong J; Tung A; Kinkade A; Tejani AM
    J Clin Epidemiol; 2019 Apr; 108():144-146. PubMed ID: 30529004
    [No Abstract]   [Full Text] [Related]  

  • 16. Equivalence and noninferiority trials.
    Siegel JP
    Am Heart J; 2000 Apr; 139(4):S166-70. PubMed ID: 10740125
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluating equivalence and noninferiority trials.
    Dasgupta A; Lawson KA; Wilson JP
    Am J Health Syst Pharm; 2010 Aug; 67(16):1337-43. PubMed ID: 20689122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretation and inference in noninferiority randomized controlled trials in drug research.
    Wangge G; Klungel OH; Roes KC; de Boer A; Hoes AW; Knol MJ
    Clin Pharmacol Ther; 2010 Sep; 88(3):420-3. PubMed ID: 20668448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D; Kim MY
    Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific statistical considerations relevant to the design and analysis of gingivitis trials demonstrating product superiority or equivalence.
    Kingman A
    J Periodontal Res; 1992 Jul; 27(4 Pt 2):378-89; discussion 390-4. PubMed ID: 1507027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.